Clinical Trial: Long-Term Follow-Up Analysis of a Phase II Study of Durvalumab Plus Concurrent Definitive Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer (WJOG11619L: DOLPHIN Study) (WJOG11619LFS) (Japan)

Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061522) titled 'Long-Term Follow-Up Analysis of a Phase II Study of Durvalumab Plus Concurrent Definitive Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer (WJOG11619L: DOLPHIN Study) (WJOG11619LFS)' on May 12.

Study Type: Observational

Primary Sponsor: Institute - West Japan Oncology Group

Condition: Condition - Non-small cell lung cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - The objective is to evaluate the efficacy and safety of durvalumab in combination with definitive radiotherapy through long-term follow-up. Basic objectives2 ...